Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Fresenius Medical Care AG (FMS) over the last 16 years, with Q3 2025 value amounting to -$63.1 million.

  • Fresenius Medical Care AG's Cash from Investing Activities rose 7386.09% to -$63.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$465.2 million, marking a year-over-year decrease of 54355.67%. This contributed to the annual value of -$90.8 million for FY2024, which is 8449.93% up from last year.
  • Fresenius Medical Care AG's Cash from Investing Activities amounted to -$63.1 million in Q3 2025, which was up 7386.09% from -$160.8 million recorded in Q2 2025.
  • Fresenius Medical Care AG's 5-year Cash from Investing Activities high stood at $347.4 million for Q2 2024, and its period low was -$483.7 million during Q4 2021.
  • Its 5-year average for Cash from Investing Activities is -$168.9 million, with a median of -$164.5 million in 2023.
  • Per our database at Business Quant, Fresenius Medical Care AG's Cash from Investing Activities surged by 33922.05% in 2024 and then crashed by 14629.26% in 2025.
  • Quarter analysis of 5 years shows Fresenius Medical Care AG's Cash from Investing Activities stood at -$483.7 million in 2021, then skyrocketed by 52.55% to -$229.5 million in 2022, then surged by 54.76% to -$103.8 million in 2023, then fell by 22.67% to -$127.4 million in 2024, then soared by 50.43% to -$63.1 million in 2025.
  • Its Cash from Investing Activities was -$63.1 million in Q3 2025, compared to -$160.8 million in Q2 2025 and -$113.9 million in Q1 2025.